Hemrajani Rekha
CIK 0001771213
Director
Filings
15
Latest Jan 21, 2026
Issuers covered
4
Showing
15 of 15
Page 1
Track record
3 of 3 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 3 | 33% | +2.7% | -0.9% | +15.0% | -6.0% |
| 90 days | 3 | 33% | -28.9% | -38.0% | +23.3% | -72.0% |
| 180 days | 3 | 33% | -40.1% | -66.3% | +26.9% | -81.0% |
| 365 days | 2 | 0% | -50.9% | -50.9% | -27.7% | -74.0% |
Issuers
Companies where Hemrajani Rekha has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ALXO | Alx Oncology Holdings Inc | 6 | Jan 21, 2026 |
| MXCT | Maxcyte, Inc. | 5 | Aug 27, 2025 |
| BIOA | Bioage Labs, Inc. | 3 | Jun 9, 2025 |
| LBRX | Lb Pharmaceuticals Inc | 1 | Sep 12, 2025 |
All filings
15 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|